Cardiovascular Drugs Practice Questions

Q: A 38-year-old woman being treated for hypertension and diabetes presents with the sudden onset of swelling and tenderness of the wrists and knees. On examination, she is febrile and flushed. A friction rub can be heard at the left lower sternal border. Which of the following drugs is most likely the cause of these findings?

Hydralazine. **Explanation:** The clinical presentation of fever, joint pain (polyarthritis), and a pericardial friction rub (indicating pericarditis) in a patient on antihypertensive therapy is classic for **Drug-Induced Lupus Erythematosus (DILE)**. **1. Why Hydralazine is correct:** Hydralazine is a potent vasodilator used in resistant hypertension. It is one of the most common causes of DILE. The mechanism involves the accumulation of reactive metabolites that trigger an autoimmune response. A key high-yield feature of Hydralazine-induced lupus is its association with **"Slow Acetylators"** (individuals with a genetic deficiency in the N-acetyltransferase enzyme), who cannot metabolize the drug efficiently, leading to toxicity. **2. Why the other options are incorrect:** * **Metformin:** Primarily causes gastrointestinal upset or lactic acidosis; it does not cause lupus-like syndromes. * **Minoxidil:** While it can cause pericardial effusion, it typically presents with hypertrichosis (excessive hair growth) and fluid retention, not a systemic autoimmune/lupus-like picture. * **Nitroprusside:** Used for hypertensive emergencies; its main toxicity is cyanide or thiocyanate poisoning (presenting with altered mental status and metabolic acidosis). **3. NEET-PG High-Yield Pearls:** * **Hallmark Antibody:** Anti-histone antibodies are positive in >95% of DILE cases (Anti-dsDNA is usually negative, unlike systemic lupus). * **Common Culprits (SHIPP):** **S**ulfonamides, **H**ydralazine, **I**soniazid, **P**rocainamide, **P**henytoin. * **Clinical Distinction:** DILE rarely involves the CNS or Kidneys, which helps distinguish it from idiopathic SLE. * **Management:** Symptoms typically resolve upon discontinuation of the offending drug.

Q: Which beta-blocker exhibits additional nitric oxide activity?

Nebivolol. ### Explanation **Correct Answer: D. Nebivolol** **Mechanism of Action:** Nebivolol is a **third-generation, highly selective β1-receptor antagonist**. Its unique pharmacological profile stems from its ability to stimulate **endothelial nitric oxide synthase (eNOS)** via β3-agonistic activity. This leads to the release of **Nitric Oxide (NO)**, which induces vasodilation, reduces peripheral vascular resistance, and improves endothelial function. This dual action (β1-blockade + NO-mediated vasodilation) makes it distinct from traditional beta-blockers. **Analysis of Incorrect Options:** * **A. Atenolol:** A second-generation, cardioselective (β1) blocker. It is hydrophilic and lacks any vasodilatory or NO-releasing properties. * **B. Metoprolol:** A standard second-generation β1-selective blocker. While widely used, it does not possess additional vasodilatory mechanisms like NO release. * **C. Bisoprolol:** A highly selective β1-blocker used primarily in heart failure. Like metoprolol, its action is limited to sympathetic blockade without direct effects on nitric oxide. **High-Yield Clinical Pearls for NEET-PG:** * **Selectivity:** Nebivolol is the **most β1-selective** blocker currently available. * **Vasodilatory Beta-blockers:** Remember the "third-generation" group: * **Nebivolol:** Via Nitric Oxide (NO) release. * **Carvedilol & Labetalol:** Via α1-receptor blockade. * **Celiprolol:** Via β2-agonist activity. * **Clinical Benefit:** Due to NO release, Nebivolol has a lower incidence of erectile dysfunction and metabolic side effects (like insulin resistance) compared to older beta-blockers.

Q: A 40-year-old male presents to the emergency department with an altered level of consciousness. On examination, his blood pressure is 210/152 mmHg and he has severe papilledema. Which of the following drugs, administered via intravenous infusion, acts on GPCRs and has a very short duration of action?

Fenoldopam. ### Explanation **Correct Answer: A. Fenoldopam** The patient is presenting with a **Hypertensive Emergency** (BP >180/120 mmHg with target organ damage, evidenced by altered consciousness and papilledema) [1]. **Why Fenoldopam is correct:** * **Mechanism of Action:** Fenoldopam is a selective **Dopamine D1 receptor agonist**. Since D1 receptors are **G-Protein Coupled Receptors (GPCRs)**, it fits the question's criteria. * **Pharmacokinetics:** It is administered via IV infusion and has a **very short half-life** (approx. 5–10 minutes), allowing for precise titration. * **Clinical Benefit:** It causes systemic vasodilation and, uniquely, increases renal blood flow and promotes natriuresis, making it highly beneficial in patients with renal impairment. **Why the other options are incorrect:** * **B. Hydralazine:** It is a direct vasodilator [2]. While used in pregnancy-induced hypertension, its duration of action is longer and less predictable, and its primary mechanism is not via GPCRs. * **C. Metoprolol:** While it acts on GPCRs ($\beta_1$ receptors), it is a $\beta$-blocker. In hypertensive emergencies, pure $\beta$-blockers are rarely first-line unless there is aortic dissection, as they can cause "unopposed alpha activity." * **D. Nitroprusside:** Although it is short-acting and used in emergencies, it acts by releasing **Nitric Oxide (NO)**, which directly activates **soluble Guanylyl Cyclase** [2]. It does not act via a GPCR. **High-Yield Clinical Pearls for NEET-PG:** * **Fenoldopam side effect:** It can increase intraocular pressure; use with caution in **Glaucoma**. * **Nitroprusside toxicity:** Prolonged infusion can lead to **Cyanide/Thiocyanate toxicity** (treated with Sodium Thiosulfate). * **Drug of Choice (DOC):** For most hypertensive emergencies, **Labetalol** or **Nicardipine** are commonly used, but Fenoldopam is the specific answer when "D1 agonist" or "renal preservation" is hinted.

Q: All are true about Carvedilol except?

It is a cardioselective beta-blocker. **Explanation:** **Why Option C is the correct answer (The "Except" statement):** Carvedilol is a **non-selective beta-blocker** (blocks both $\beta_1$ and $\beta_2$ receptors) that also possesses **$\alpha_1$-blocking** activity. [1] It does not exhibit cardioselectivity. Cardioselective beta-blockers (like Metoprolol, Bisoprolol, and Atenolol) primarily target $\beta_1$ receptors. Carvedilol’s additional $\alpha_1$ blockade leads to peripheral vasodilation, which reduces afterload—a distinct advantage in managing heart failure. **Analysis of other options:** * **Option A:** Carvedilol is a first-line agent in **Chronic Congestive Heart Failure (CHF)**. It reduces remodeling, decreases mortality, and improves ejection fraction. [3] * **Option B:** Beyond receptor blockade, Carvedilol has unique **antioxidant** (scavenges free radicals) and **anti-inflammatory** properties, which protect the myocardium from oxidative stress. [1] * **Option D:** In CHF, beta-blockers must be started at **"low dose and titrated slowly"** (Start low, go slow). This prevents acute decompensation due to the initial negative inotropic effect, allowing the heart to adapt to the long-term benefits of sympathetic blockade. **High-Yield Clinical Pearls for NEET-PG:** * **Generation:** Carvedilol is a **3rd generation** (vasodilatory) beta-blocker. [2] * **Lipophilicity:** It is highly lipid-soluble and undergoes extensive first-pass metabolism. * **Metabolic Profile:** Unlike older beta-blockers, Carvedilol is metabolically neutral or may improve insulin sensitivity. * **FDA Approved for CHF:** Only three beta-blockers are proven to reduce mortality in CHF: **Carvedilol, Bisoprolol, and Metoprolol Succinate** (long-acting). [2], [3]

Q: Drugs associated with clinically useful or physiologically important positive inotropic effects include all of the following except?

Enalapril. **Explanation:** The core of this question lies in understanding the mechanism of **Inotropy** (the force of myocardial contraction). Positive inotropic agents increase the concentration of intracellular calcium or the sensitivity of contractile proteins to calcium, thereby increasing cardiac output. **Why Enalapril is the Correct Answer:** **Enalapril** is an **ACE Inhibitor**. Its primary mechanism involves inhibiting the conversion of Angiotensin I to Angiotensin II and preventing the breakdown of bradykinin. This leads to systemic vasodilation (decreased afterload) and reduced salt/water retention (decreased preload). While Enalapril is a cornerstone in treating Heart Failure because it reduces cardiac workload and prevents remodeling, it has **no direct positive inotropic effect** on the myocardium. **Analysis of Incorrect Options:** * **Amrinone (and Milrinone):** These are **PDE-3 inhibitors**. They prevent the breakdown of cAMP in cardiac muscle, leading to increased calcium influx and increased contractility (Inodilators). * **Digoxin:** A **Cardiac Glycoside** that inhibits the Na+/K+ ATPase pump. This indirectly leads to an increase in intracellular calcium via the Na+/Ca2+ exchanger, resulting in a potent positive inotropic effect. * **Dobutamine:** A selective **Beta-1 agonist**. It stimulates Gs-coupled receptors to increase cAMP, directly enhancing myocardial contractility. **NEET-PG High-Yield Pearls:** * **Inodilators:** Drugs like Milrinone and Levosimendan provide both positive inotropy and vasodilation. * **Levosimendan:** Acts as a **Calcium sensitizer**; it increases contractility without increasing myocardial oxygen demand significantly. * **ACE Inhibitors:** Known as "Life-prolonging drugs" in heart failure, but they are **not** inotropes. * **Digoxin Toxicity:** Characterized by xanthopsia (yellow vision) and various arrhythmias (most specific being Atrial Tachycardia with AV block).

Q: Which of the following anti-angina drugs acts by inhibition of long-chain 3-ketoacyl coenzyme A thiolase?

Trimetazidine. ### Explanation **Correct Option: A. Trimetazidine** Trimetazidine is a **pFOX inhibitor** (partial fatty acid oxidation inhibitor). It works by inhibiting the enzyme **long-chain 3-ketoacyl coenzyme A thiolase (3-KAT)**. * **Mechanism:** Under normal conditions, the heart derives energy from fatty acid oxidation, which requires more oxygen. By inhibiting 3-KAT, Trimetazidine shifts myocardial metabolism from fatty acid oxidation to **glucose oxidation**. * **Benefit:** Glucose oxidation is more oxygen-efficient, allowing the heart to produce more ATP per molecule of oxygen consumed, thereby protecting the myocardium during ischemic episodes without affecting heart rate or blood pressure. **Incorrect Options:** * **B. Ivabradine:** Acts by selectively inhibiting the **funny current ($I_f$)** in the sinoatrial (SA) node. It reduces heart rate without affecting myocardial contractility or BP. * **C. Ranolazine:** Primarily acts by inhibiting the **late inward sodium current ($I_{Na}$)** in cardiomyocytes. This prevents calcium overload and improves diastolic relaxation. * **D. Nicorandil:** A dual-action drug that acts as a **K+ATP channel opener** (causing arterial vasodilation) and a **Nitric Oxide (NO) donor** (causing venodilation). **High-Yield Clinical Pearls for NEET-PG:** * **Trimetazidine** is often used as add-on therapy in stable angina; however, it is contraindicated in patients with **Parkinson’s disease** as it may worsen extrapyramidal symptoms. * **Ivabradine** is specifically indicated in patients with stable angina who have a contraindication to Beta-blockers, provided they are in **sinus rhythm**. * **Nicorandil** can cause a unique side effect: **persistent mucosal ulcerations** (e.g., oral, anal, or GI ulcers).

Q: Which of the following antihypertensive drugs inhibits the vesicular uptake of norepinephrine?

Reserpine. ### Explanation **Correct Option: C. Reserpine** Reserpine is an alkaloid derived from *Rauwolfia serpentina*. Its primary mechanism of action is the **irreversible inhibition of the Vesicular Monoamine Transporter (VMAT-2)**. * **Mechanism:** Under normal conditions, VMAT-2 transports free norepinephrine (NE), dopamine, and serotonin from the cytoplasm into storage vesicles. By blocking VMAT-2, reserpine prevents the vesicular uptake and storage of these neurotransmitters. * **Result:** The unprotected NE in the cytoplasm is degraded by the enzyme **Monoamine Oxidase (MAO)**, leading to a profound depletion of catecholamines in sympathetic nerve terminals, which results in a decrease in blood pressure and heart rate. **Analysis of Incorrect Options:** * **A. Propranolol:** A non-selective **beta-blocker** ($β_1$ and $β_2$). it acts by antagonizing adrenergic receptors, not by affecting neurotransmitter storage or uptake. * **B. Prazosin:** A selective **alpha-1 ($α_1$) blocker**. It causes vasodilation by blocking postsynaptic receptors on vascular smooth muscle. * **D. Guanethidine:** This drug inhibits the **release** of norepinephrine from the nerve terminal and displaces NE from vesicles, but it does not primarily act by inhibiting the VMAT-2 uptake pump like reserpine. **High-Yield Clinical Pearls for NEET-PG:** * **Depression Warning:** Because reserpine also depletes serotonin and dopamine in the CNS, it is notorious for causing **severe mental depression** and is contraindicated in patients with a history of depressive illness. * **Gastrointestinal Effects:** By depleting sympathetic tone, it leads to parasympathetic dominance, causing increased gastric acid secretion (risking peptic ulcers) and diarrhea. * **VMAT-1 vs VMAT-2:** VMAT-1 is found in neuroendocrine cells (adrenal medulla), while **VMAT-2** is the primary target in the CNS and peripheral postganglionic neurons.

Q: What is the primary effect of Nicotinic acid?

Increases HDL. **Explanation:** **Nicotinic Acid (Niacin)** is a potent lipid-lowering agent. Its **primary and most significant effect is increasing HDL levels** (by 15–35%), making it the most effective drug currently available for this purpose. 1. **Why Option A is Correct:** Niacin increases HDL levels by decreasing the fractional fractional clearance of apoA-I (the primary apolipoprotein of HDL) in the liver. This prolongs the half-life of HDL particles, enhancing reverse cholesterol transport. 2. **Why Options B, C, and D are Incorrect:** * **Option B:** Niacin actually **decreases** triglyceride synthesis by inhibiting diacylglycerol acyltransferase-2 (DGAT2) in the liver. * **Option C:** While Niacin can be used as an adjunct, **Statins** are the first-line treatment for Type II hyperlipoproteinemia (Hypercholesterolemia). Niacin is more specifically indicated for Type IV and V (Hypertriglyceridemia). * **Option D:** Niacin **inhibits the lipolysis of triglycerides** in adipose tissue by inhibiting the enzyme hormone-sensitive lipase (HSL). This reduces the flow of free fatty acids to the liver, thereby decreasing VLDL production, rather than decreasing VLDL hydrolysis. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Acts via G protein-coupled receptors (GPR109A) to inhibit hormone-sensitive lipase in adipose tissue. * **Side Effects:** The most common side effect is **cutaneous flushing** (mediated by Prostaglandin $D_2$ and $E_2$; prevented by Aspirin). * **Metabolic Complications:** Can cause **hyperuricemia** (precipitating gout) and **hyperglycemia** (impaired glucose tolerance), so it must be used cautiously in diabetic patients. * **Acanthosis Nigricans:** Niacin therapy is a known pharmacological cause of this skin condition.

Q: Which ECG findings represent a characteristic manifestation of digitalis toxicity?

Atrial tachycardia with variable block. **Explanation:** **Atrial tachycardia with variable AV block** is considered the most characteristic (pathognomonic) arrhythmia of digitalis toxicity. This occurs due to the dual action of Digoxin: 1. **Increased Automaticity:** Digoxin inhibits the Na+/K+ ATPase pump, leading to intracellular Calcium overload, which increases the firing rate of atrial ectopic foci (causing tachycardia). 2. **Increased Vagomimetic Effect:** Digoxin increases vagal tone, which slows conduction through the AV node (causing the block). The combination of a rapid atrial rate with a blocked conduction is a classic "signature" of Digoxin overdose. **Analysis of Incorrect Options:** * **A & B (ST-segment depression and T-wave inversion):** These are common ECG changes seen with **therapeutic** doses of Digoxin (often described as a "reverse tick" or "scooped" ST segment). While present in toxicity, they are not specific to it. * **C (Atrial flutter):** Digoxin is actually used to treat atrial flutter by increasing the AV block; it is rarely caused by the drug itself. **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Arrhythmia:** Ventricular Bigeminy (PVCs). * **Most Characteristic Arrhythmia:** Atrial tachycardia with block. * **Most Common Cause of Death:** Ventricular Fibrillation. * **Electrolyte Triggers:** Hypokalemia, Hypomagnesemia, and Hypercalcemia predispose to toxicity. * **Antidote:** Digoxin-specific antibody fragments (DigiFab/Digibind). * **Visual Side Effect:** Xanthopsia (yellowish-green vision).

Question 1

A 38-year-old woman being treated for hypertension and diabetes presents with the sudden onset of swelling and tenderness of the wrists and knees. On examination, she is febrile and flushed. A friction rub can be heard at the left lower sternal border. Which of the following drugs is most likely the cause of these findings?

Accepted Answer

Hydralazine

Answer

Metformin

Answer

Minoxidil

Answer

Nitroprusside

Question 2

Which beta-blocker exhibits additional nitric oxide activity?

Accepted Answer

Nebivolol

Answer

Atenolol

Answer

Metoprolol

Answer

Bisoprolol

Question 3

A 40-year-old male presents to the emergency department with an altered level of consciousness. On examination, his blood pressure is 210/152 mmHg and he has severe papilledema. Which of the following drugs, administered via intravenous infusion, acts on GPCRs and has a very short duration of action?

Accepted Answer

Fenoldopam

Answer

Hydralazine

Answer

Metoprolol

Answer

Nitroprusside

Question 4

All are true about Carvedilol except?

Accepted Answer

It is a cardioselective beta-blocker

Answer

Used in chronic congestive heart failure

Answer

It also has antioxidant and anti-inflammatory properties

Answer

Beta-blockers are started at low doses and gradually increased till maximum recommended dose

Question 5

Organic nitrates can lead to the development of tolerance when used chronically. Which of the following preparations is least likely to develop tolerance?

Accepted Answer

Sublingual nitroglycerine

Answer

Sustained release oral nitroglycerine

Answer

Transdermal nitroglycerine

Answer

Oral pentaerythritol tetranitrate

Question 6

Drugs associated with clinically useful or physiologically important positive inotropic effects include all of the following except?

Accepted Answer

Enalapril

Answer

Amrinone

Answer

Digoxin

Answer

Dobutamine

Question 7

Which of the following anti-angina drugs acts by inhibition of long-chain 3-ketoacyl coenzyme A thiolase?

Accepted Answer

Trimetazidine

Answer

Ivabradine

Answer

Ranolazine

Answer

Nicorandil

Question 8

Which of the following antihypertensive drugs inhibits the vesicular uptake of norepinephrine?

Accepted Answer

Reserpine

Answer

Propranolol

Answer

Prazosin

Answer

Guanithidine

Question 9

What is the primary effect of Nicotinic acid?

Accepted Answer

Increases HDL

Answer

Increases triglyceride synthesis

Answer

Treats Type II hyperlipoproteinemia

Answer

Decreases hydrolysis of VLDL

Question 10

Which ECG findings represent a characteristic manifestation of digitalis toxicity?

Accepted Answer

Atrial tachycardia with variable block

Answer

ST-segment depression

Answer

T-wave inversion

Answer

Atrial flutter

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?